Metastatic melanoma cells with BRAF G469A mutation: nab-paclitaxel better than vemurafenib?
Porcelli, Letizia, Guida, Gabriella, Tommasi, Stefania, Guida, Michele, Azzariti, AmaliaVolume:
76
Language:
english
Journal:
Cancer Chemotherapy and Pharmacology
DOI:
10.1007/s00280-015-2796-6
Date:
August, 2015
File:
PDF, 606 KB
english, 2015